Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

High affinity of interaction between superantigen and T cell receptor Vbeta molecules induces a high level and prolonged expansion of superantigen-reactive CD4+ T cells.

Omoe K, Nunomura W, Kato H, Li ZJ, Igarashi O, Araake M, Sano K, Ono HK, Abe Y, Hu DL, Nakane A, Kiyono H, Takakuwa Y, Shinagawa K, Uchiyama T, Imanishi K.

J Biol Chem. 2010 Oct 1;285(40):30427-35. doi: 10.1074/jbc.M110.140871. Epub 2010 Jul 27.

2.

Molecular epidemiology of outbreaks and containment of drug-resistant Pseudomonas aeruginosa in a Tokyo hospital.

Sekiguchi J, Teruya K, Horii K, Kuroda E, Konosaki H, Mizuguchi Y, Araake M, Kawana A, Yoshikura H, Kuratsuji T, Miyazaki H, Kirikae T.

J Infect Chemother. 2007 Dec;13(6):418-22. Epub 2007 Dec 25.

PMID:
18095093
3.

Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan.

Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Kasai A, Mizuguchi Y, Araake M, Fujino T, Kikuchi H, Sasaki S, Watari H, Kojima T, Miki H, Kanemitsu K, Kunishima H, Kikuchi Y, Kaku M, Yoshikura H, Kuratsuji T, Kirikae T.

J Clin Microbiol. 2007 Mar;45(3):979-89. Epub 2006 Nov 22.

4.

Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus in tuberculosis wards.

Sekiguchi J, Fujino T, Araake M, Toyota E, Kudo K, Saruta K, Yoshikura H, Kuratsuji T, Kirikae T.

J Infect Chemother. 2006 Feb;12(1):47-50.

PMID:
16506090
5.

Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454).

Sekiguchi J, Tharavichitkul P, Miyoshi-Akiyama T, Chupia V, Fujino T, Araake M, Irie A, Morita K, Kuratsuji T, Kirikae T.

Antimicrob Agents Chemother. 2005 Sep;49(9):3948-51.

6.

Detection of the antiseptic- and disinfectant-resistance genes qacA, qacB, and qacC in methicillin-resistant Staphylococcus aureus isolated in a Tokyo hospital.

Sekiguchi J, Hama T, Fujino T, Araake M, Irie A, Saruta K, Konosaki H, Nishimura H, Kawano A, Kudo K, Kondo T, Sasazuki T, Kuratsuji T, Yoshikura H, Kirikae T.

Jpn J Infect Dis. 2004 Dec;57(6):288-91. No abstract available.

7.

Prognostic significance of thymidylate synthase in patients with metastatic colorectal cancer who receive protracted venous infusions of 5-fluorouracil.

Hosokawa A, Yamada Y, Shimada Y, Muro K, Hamaguchi T, Morita H, Araake M, Orita H, Shirao K.

Int J Clin Oncol. 2004 Oct;9(5):388-92.

PMID:
15549590
9.

[Antibacterial activity of biapenem against recent clinical isolates].

Hara T, Araake M, Watabe H.

Jpn J Antibiot. 2003 Apr;56(2):138-41. Japanese.

PMID:
12825414
10.

[Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].

Tabata M, Shimizu M, Araake M, Ogawa H.

Jpn J Antibiot. 2003 Feb;56(1):36-43. Japanese.

PMID:
12723397
11.

[Inhibitory activity of NM394, the active form of prodrug prulifloxacin against type II topoisomerase from Pseudomonas aeruginosa].

Tani M, Maebashi K, Araake M, Watabe H.

Jpn J Antibiot. 2002 Dec;55(6):882-5. Japanese.

PMID:
12621742
12.
14.

[In vitro antibacterial activity of prulifloxacin, a new oral fluoroquinolone].

Araake M, Hara T, Watabe H, Nishino T.

Jpn J Antibiot. 2002 Dec;55(6):778-90. Japanese.

PMID:
12621732
15.

In vitro antiseptic susceptibility of clinical isolates from nosocomial infections.

Shimizu M, Okuzumi K, Yoneyama A, Kunisada T, Araake M, Ogawa H, Kimura S.

Dermatology. 2002;204 Suppl 1:21-7.

PMID:
12011516
16.

[Bactericidal activity of biapenem against various efflux system mutants of Pseudomonas aeruginosa].

Hiraishi T, Miyata A, Takata T, Araake M, Ogawa H, Gotoh N, Nishino T.

Jpn J Antibiot. 2002 Feb;55(1):67-76. Japanese.

PMID:
11977922
17.

[Bactericidal activity of biapenem against various bacteria].

Hiraishi T, Miyata A, Hara T, Araake M, Ogawa H.

Jpn J Antibiot. 2001 Dec;54(12):581-95. Japanese.

PMID:
11877858
18.

[Effect of arbekacin on the production of toxic shock syndrome toxin 1 by methicillin-resistant Staphylococcus aureus].

Miyata A, Araake M, Ogawa H, Hanaki H, Hiramatsu K.

Jpn J Antibiot. 2001 Jul;54(7):372-81. Japanese.

PMID:
11560056
19.

[Combination effect of arbekacin and cefepime on mixed culture of MRSA and P. aeruginosa].

Araake M, Hara T, Miyata A, Tani M, Ogawa H.

Jpn J Antibiot. 2001 Feb;54(2):69-78. Japanese.

PMID:
11338680
20.
21.
22.

The effects of serum on cellular uptake and phototoxicity of mono-L-aspartyl chlorin e6 (NPe6) in vitro.

Sheyhedin I, Aizawa K, Araake M, Kumasaka H, Okunaka T, Kato H.

Photochem Photobiol. 1998 Jul;68(1):110-4.

PMID:
9679456
23.

Airway hyperresponsiveness to histamine in mycoplasmal infection: role of histamine N-methyltransferase.

Tamaoki J, Araake M, Chiyotani A, Isono K, Nagai A.

Eur J Pharmacol. 1998 Apr 24;347(2-3):257-60.

PMID:
9653891
24.

Cladinose analogues of sixteen-membered macrolide antibiotics. V. Preparation of unsubstituted L-cladinose analogues: effect of methylation of a 3"-hydroxyl group on the bioactivity.

Ajito K, Shimizu A, Shibahara S, Hara O, Kurihara K, Araake M, Tohyama K, Miyadoh S, Omoto S, Inouye S.

J Antibiot (Tokyo). 1997 Apr;50(4):366-9. No abstract available.

25.

Cladinose analogues of sixteen-membered macrolide antibiotics. IV. Improved therapeutic effects of 4-O-acyl-L-cladinose analogues of sixteen-membered macrolide antibiotics.

Ajito K, Kurihara K, Shibahara S, Hara O, Okonogi T, Kikuchi N, Araake M, Suzuki H, Omoto S, Inouye S.

J Antibiot (Tokyo). 1997 Feb;50(2):150-61.

26.

Cladinose analogues of sixteen-membered macrolide antibiotics. II. Preparation of pharmacokinetically improved analogues via biotransformation.

Ajito K, Kurihara K, Shibahara S, Hara O, Shimizu A, Araake M, Omoto S.

J Antibiot (Tokyo). 1997 Jan;50(1):92-5. No abstract available.

27.

Modulatory effect of antibiotics on cytokine production by human monocytes in vitro.

Morikawa K, Watabe H, Araake M, Morikawa S.

Antimicrob Agents Chemother. 1996 Jun;40(6):1366-70.

28.

Cladinose analogues of sixteen-membered macrolide antibiotics. I. Synthesis of 4-O-alkyl-L-cladinose analogues via glycosylation.

Kurihara K, Ajito K, Shibahara S, Ishizuka T, Hara O, Araake M, Omoto S.

J Antibiot (Tokyo). 1996 Jun;49(6):582-92.

29.

[Evaluation of once-daily administration of arbekacin. Experimental study and determination of pharmacokinetic properties in man].

Totsuka K, Shimizu K, Mitomi N, Niizato T, Araake M.

Jpn J Antibiot. 1994 Jun;47(6):676-92. Japanese.

PMID:
8072176
31.
32.

Relative ability of distinct isotypes of human major histocompatibility complex class II molecules in binding staphylococcal enterotoxin A.

Saito S, Imanishi K, Araake M, Yan XJ, Igarashi H, Uchiyama T.

Microbiol Immunol. 1991;35(8):661-73.

35.

Activation of V beta 11+ murine T cells by staphylococcal enterotoxin E in the presence of accessory cells expressing MHC class II molecules.

Uchiyama T, Yan XJ, Imanishi K, Araake M, Kawachi A, Tachihara R, Shinagawa K.

Jpn J Med Sci Biol. 1990 Dec;43(6):277. No abstract available.

PMID:
2101161
36.

Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.

Uchiyama T, Tadakuma T, Imanishi K, Araake M, Saito S, Yan XJ, Fujikawa H, Igarashi H, Yamaura N.

J Immunol. 1989 Nov 15;143(10):3175-82.

PMID:
2509554
37.

Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.

Uchiyama T, Imanishi K, Saito S, Araake M, Yan XJ, Fujikawa H, Igarashi H, Kato H, Obata F, Kashiwagi N, et al.

Eur J Immunol. 1989 Oct;19(10):1803-9.

PMID:
2583222
38.

Attachment of Mycoplasma pulmonis to rat and mouse synovial cells cultured in vitro.

Araake M, Yayoshi M, Yoshioka M.

Microbiol Immunol. 1985;29(7):601-7.

39.

Immunogenicity and protective effect of hemolysis mutants of Mycoplasma pneumoniae.

Yayoshi M, Araake M, Hayatsu E, Takezawa T, Yoshioka M.

Microbiol Immunol. 1985;29(11):1029-37.

40.

Electron microscopic studies on the attachment of Mycoplasma pulmonis to mouse synovial cells cultured in vitro.

Araake M, Yayoshi M, Yoshioka M.

Microbiol Immunol. 1984;28(3):379-84. No abstract available.

41.

Characterization and pathogenicity of hemolysis mutants of Mycoplasma pneumoniae.

Yayoshi M, Araake M, Hayatsu E, Kawakubo Y, Yoshioka M.

Microbiol Immunol. 1984;28(3):303-10.

42.
43.

Immunological responses of hamsters in the acquired immune state to Mycoplasma pneumoniae infection.

Hayatsu E, Kawakubo Y, Yayoshi M, Araake M, Wakai M, Yoshida A, Yoshioka M, Nishiyama Y.

Microbiol Immunol. 1981;25(12):1255-63.

44.

[Analytical examination of bacteria in a neonatal intensive care unit (author's transl)].

Yoshioka M, Sushida K, Nakano H, Yayoshi M, Araake M, Ito T, Kono M, Wakai M, Yokota K, Uramoto K.

Kansenshogaku Zasshi. 1980 Dec;54(12):789-97. Japanese. No abstract available.

PMID:
6788864
45.

Mycoplasma pulmonis arthritis in congenitally athymic (nude) mice. Histopathological features.

Kono M, Tanaka H, Yayoshi M, Araake M, Yoshioka M, Imai M.

Microbiol Immunol. 1980;24(5):381-91.

46.

Role of humoral antibodies in resistance to Mycoplasma pneumoniae pneumonia in hamsters.

Hayatsu E, Kawakubo Y, Yayoshi M, Araake M, Yoshioka M, Nishiyama Y.

Microbiol Immunol. 1980;24(7):585-93.

47.

[Scanning electron microscopy of drug resistant Mycobacterium tuberculosis (author's transl)].

Araake M, Sushida K.

Kekkaku. 1979 Jun;54(6):325-30. Japanese. No abstract available.

PMID:
116051
48.

[Effect of fatty acids on the growth of Mycoplasma].

Yakichi M, Araake M, Yoshioka M.

Nihon Saikingaku Zasshi. 1975 Jan;30(1):211. Japanese. No abstract available.

PMID:
1240244

Supplemental Content

Loading ...
Support Center